Результаты поиска
Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску
- ...}}</ref> and has 100-fold lower [[affinity (pharmacology)|affinity]] for [[GPER]] (GPR30) relative to [[estradiol]].<ref name="pmid20138435">{{cite journal [[Category:GPER agonists]] ...7 Кб (795 слов) - 03:52, 27 февраля 2024
- ...It is also an [[agonist]] of the [[G protein-coupled estrogen receptor]] (GPER) with relatively low [[affinity (pharmacology)|affinity]] (100–1,000  [[Category:GPER agonists]] ...7 Кб (868 слов) - 16:54, 1 января 2024
- ...t1=E.R. |last2=Barton|first2=M. |title=Estrogen biology: New insights into GPER function and clinical opportunities|journal=Molecular and Cellular Endocrin [[Category:GPER agonists]] ...12 Кб (1472 слова) - 02:00, 24 февраля 2024
- ...rotein-Coupled Receptor 30 (GPR30) or G-Protein-Coupled Estrogen Receptor (GPER) | series = Methods in Molecular Biology | volume = 1366 | pages = 11–7 | [[Category:GPER agonists]] ...10 Кб (1212 слов) - 13:51, 21 декабря 2023
- ...| date = Jan 1998 | pmid = 9479505 | doi = 10.1006/geno.1998.5095 }}</ref> GPER binds to and is activated by the female sex hormone [[estradiol]] and is re ...stradiol, GPR30 was renamed as G protein-coupled estrogen receptor (GPER). GPER is localized in the plasma membrane but is predominantly detected in the [[ ...35 Кб (4434 слова) - 23:31, 10 марта 2024
- ...or antagonist|antagonist]] of the [[G protein-coupled estrogen receptor]] (GPER) (100–1,000 μM).<ref name="pmid26023144">{{cite journal | vauthors ...rotein-Coupled Receptor 30 (GPR30) or G-Protein-Coupled Estrogen Receptor (GPER)|volume=1366|year=2016|pages=11–17|issn=1064-3745|doi=10.1007/978-1-4939- ...13 Кб (1534 слова) - 13:50, 21 декабря 2023
- ...g [[Gonadotropin-releasing hormone|luteinizing hormone releasing hormone]] agonists, such as [[Goserelin|goserilin]]). In postmenopausal women, the ovaries cea ...ER modulators]] (SERMs), like [[tamoxifen]]. SERMs act as partial estrogen agonists, competing with estrogen to bind ER. ...27 Кб (3854 слова) - 18:19, 3 марта 2024
- ...|last2=Barton |first2=Matthias |title=Estrogen biology: New insights into GPER function and clinical opportunities |journal=Molecular and Cellular Endocri [[Category:GPER agonists]] ...16 Кб (2077 слов) - 03:01, 18 февраля 2024
- ...uthors = Barton M | title = Position paper: The membrane estrogen receptor GPER--Clues and questions | journal = Steroids | volume = 77 | issue = 10 | page [[Category:GPER agonists]] ...24 Кб (2944 слова) - 14:24, 10 марта 2024
- ...R.|last2=Barton|first2=Matthias|title=Estrogen biology: New insights into GPER function and clinical opportunities|journal=Molecular and Cellular Endocrin [[Category:GPER agonists]] ...24 Кб (3222 слова) - 04:40, 4 марта 2024
- [[Category:GPER agonists]] ...13 Кб (1623 слова) - 00:07, 24 марта 2024
- ...elative to the normal ERα.<ref name="pmid27754803" /> A group of other ERα agonists that included [[ethinylestradiol]], [[diethylstilbestrol]], [[tamoxifen]], ...ia signaling through the [[ERβ]] and [[G protein-coupled estrogen receptor|GPER]] (i.e., that not all of the observed phenotypes may have simply been due t ...35 Кб (4605 слов) - 19:34, 4 марта 2024
- ...[[intracellular]] receptors, and [[membrane estrogen receptor]]s (mERs) ([[GPER]] (GPR30), [[ER-X]], and [[Gq-mER|G<sub>q</sub>-mER]]), which are mostly [[ ===Agonists=== ...35 Кб (4520 слов) - 19:34, 4 марта 2024
- ...|last2=Barton |first2=Matthias |title=Estrogen biology: New insights into GPER function and clinical opportunities |journal=Molecular and Cellular Endocri ...a M. |last16=Atanasov |first16=Atanas G. |year=2014 |title=Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): A review |jou ...45 Кб (5869 слов) - 01:45, 12 марта 2024
- ...eceptor]]s ([[ERα]], [[ERβ]], [[Membrane estrogen receptor|mER]]s (e.g., [[GPER]], others)) ...rmonal agent used in the treatment of endometriosis. In the 1990s the GnRH agonists have become the most frequently used drugs for the treatment of endometrios ...34 Кб (4491 слово) - 09:52, 21 марта 2024
- ...|last2=Barton |first2=Matthias |title=Estrogen biology: New insights into GPER function and clinical opportunities |journal=[[Molecular and Cellular Endoc [[Category:GPER agonists]] ...52 Кб (6959 слов) - 00:42, 4 февраля 2024
- ...1847610 | doi = 10.1016/j.mce.2006.12.010 }}</ref> Additional mERs besides GPER include [[ER-X]], [[ERx]], and [[Gq-mER|G<sub>q</sub>-mER]].<ref name="pmid [[Category:GPER agonists]] ...73 Кб (9650 слов) - 19:23, 4 марта 2024
- [[Category:GPER agonists]] ...32 Кб (4259 слов) - 13:33, 27 января 2024
- ...ors = Prossnitz ER, Barton M | title = Estrogen biology: new insights into GPER function and clinical opportunities | journal = Molecular and Cellular Endo [[Category:GPER agonists]] ...63 Кб (8491 слово) - 19:59, 9 февраля 2024
- ...estradiol in established disease was demonstrated to require expression of GPER but not ERα, and was associated with the production of the anti-inflammato [[Category:GPER agonists]] ...121 Кб (15 864 слова) - 21:00, 4 марта 2024